Have a personal or library account? Click to login

Influence of Systemic Inflammatory Response to Appearance of New Foci of Chronic Inflammation

Open Access
|Jun 2020

References

  1. 1. Arnardottir HH, Dalli J, Norling LV, Colas RA et al. Resolvin D3 is dysregulated in arthritis and reduces arthritic inflammation. J Immunol 2016; 197(6):2362-2368.10.4049/jimmunol.1502268501100627534559
  2. 2. Barden AE, Moghaddami M, Mas E et al. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins Leukot Essent Fatty Acids 2016; 107:24-29.10.1016/j.plefa.2016.03.00427033423
  3. 3. Benvenuti M, An T, Amaro E et al. Double-Edged Sword: Musculoskeletal Infection Provoked Acute Phase Response in Children. Orthop Clin North Am. 2017; 48(2):181-197.10.1016/j.ocl.2016.12.00928336041
  4. 4. Buckley CD, Gilroy DW, Serhan CN. Pro-Resolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014; 40(3):315-327.10.1016/j.immuni.2014.02.009400495724656045
  5. 5. Chiang N, Serhan CN. Structural Elucidation and Physiologic Functions of Specialized Pro-Resolving Mediators and Their Receptors. Mol Aspects Med. 2017; 58:114-129.10.1016/j.mam.2017.03.005562360128336292
  6. 6. Cho JG, Lee A, Chang W et al. Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction. Front Immunol. 2018; 9:294.10.3389/fimmu.2018.00294582619729515588
  7. 7. Colville-Nash PR, Scott DL. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Annals of the Rheumatic Diseases 1992; 51:919-925.10.1136/ard.51.7.91910047841378718
  8. 8. Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis. 2007; 10(3):149-66.10.1007/s10456-007-9074-017457680
  9. 9. Díaz-Flores L, Gutiérrez R, García-Suárez MP et al. Morphofunctional basis of the different types of angio-genesis and formation of postnatal angiogenesis-related secondary structures. Madrid Histol Histopathol 2017; 32:1239-1279.
  10. 10. DiPietro LA. Angiogenesis and wound repair: when enough is enough. Jornal of leukocyte biology 2016; 100(5), 979-984.10.1189/jlb.4MR0316-102R660806627406995
  11. 11. Elshabrawy HA, Chen Z, Volin MV et al. The Pathogenic Role of Angiogenesis in Rheumatoid Arthritis. Angiogenesis. 2015; 18(4):433-448.10.1007/s10456-015-9477-2487988126198292
  12. 12. Fredman G, Tabas I. Boosting Inflammation Resolution in Atherosclerosis. Am J Pathol 2017; 187(6):1211-1221.10.1016/j.ajpath.2017.01.018
  13. 13. Majno G. Chronic Inflammation. Am J Pathol 1998; 153(4):1035-1039.10.1016/S0002-9440(10)65648-9
  14. 14. Moshage H. Cytokines and the hepatic acute phase response. Journal of Pathology 1997; vol. 181:257-266.10.1002/(SICI)1096-9896(199703)181:3<;257::AID-PATH756>3.0.CO;2-U
  15. 15. Nathan C, Ding A. Review: Nonresolving Inflammation. Cell 2010; 140, 871-882.10.1016/j.cell.2010.02.029
  16. 16. Orlowsky EW, Kraus VB. The Role of Innate Immunity in Osteoarthritis: When Our First Line of Defense Goes on the Offensive. J Rheumatol 2015; 42(3):363-371.10.3899/jrheum.140382
  17. 17. Ridiandries A, Tan JTM, Bursill CA. The Role of Chemokines in Wound Healing. Int J Mol Sci 2018; 19(10), 3217.10.3390/ijms19103217
  18. 18. Roemer FW. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis 2011; 70(10):1804-1809.10.1136/ard.2011.150243
  19. 19. Scanzello CR, Plaas A, Crow MK. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol 2008; 20(5):565-72.
  20. 20. Scheibner KA, Lutz MA, Boodoo S et al. Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2. J Immunol 2006; 177 (2) 1272-1281.10.4049/jimmunol.177.2.1272
  21. 21. Senger DR, Davis GE. Angiogenesis Cold Spring Harb Perspect. Biol 2011; 3(8):a005090.10.1101/cshperspect.a005090
  22. 22. Serhan C.N. Novel Pro-Resolving Lipid Mediators in Inflammation Are Leads for Resolution Physiology. Nature 2014; 510(7503):92-101.10.1038/nature13479
  23. 23. Serhan CN, Yacoubian S, Yang R. Anti-Inflammatory and Pro-Resolving Lipid Mediators. Annu Rev Pathol 2008; 3:279-312.10.1146/annurev.pathmechdis.3.121806.151409
  24. 24. Serhan CN, Chiang N, Dalli J. The Resolution Code of Acute Inflammation: Novel Pro-Resolving Lipid Mediators in Resolution. Semin Immunol 2015; 27(3):200-215.10.1016/j.smim.2015.03.004
  25. 25. Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J 2017; 31(4):1273-1288.10.1096/fj.201601222R
  26. 26. Thurston G, Murphy TJ, Baluk P et al. Angiogenesis in Mice with Chronic Airway Inflammation. Am J Pathol 1998; 153(4):1099-1112.10.1016/S0002-9440(10)65654-4
  27. 27. Uddin M, Levy BD. Resolvins: Natural Agonists for Resolution of Pulmonary Inflammation. Prog Lipid Res 2011n; 50(1):75-88.10.1016/j.plipres.2010.09.002301213920887750
  28. 28. Van Caam A, Vonk M, van den Hoogen F et al. Unraveling SSc Pathophysiology; The Myofibroblast. Frontiers in Immunology 2018; 9(2452):1-22.10.3389/fimmu.2018.02452624295030483246
DOI: https://doi.org/10.2478/sjecr-2020-0013 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 3 - 10
Submitted on: Feb 17, 2020
Accepted on: Feb 23, 2020
Published on: Jun 5, 2020
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2020 Denis Dmitrievich Bolotov, Alexey Alexeevich Novikov, Sergey Bolevich, Nina Aleksandrovna Novikova, Andrey Vladimirovich Yakovchenko, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.